DESPITE nervy times in China, mainboard-listed Vicplas International : 569 0% will stick to its plan to open its third and latest medical technology (medtech) manufacturing outlet in Changzhou next month — ramping up its medical devices production capacity in the country by 60 per cent.

It currently already operates 2 medical devices manufacturing plants there: one in Changzhou and another in Xiamen.

“Quite frankly, we’ve maxed out the capacity in our other (Changzhou) plant. We have a number of projects that are reaching the end of their commercialisation phase,” said deputy group chief executive officer of Vicplas International, Walter Tarca.